These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 25860107

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
    Kornstein SG, Clayton A, Bao W, Guico-Pabia CJ.
    Menopause; 2014 Aug; 21(8):799-806. PubMed ID: 24448103
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
    Clayton AH, Kornstein SG, Dunlop BW, Focht K, Musgnung J, Ramey T, Bao W, Ninan PT.
    J Clin Psychiatry; 2013 Oct; 74(10):1010-7. PubMed ID: 24229754
    [Abstract] [Full Text] [Related]

  • 5. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 6. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
    Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan PT, Kane CP.
    CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of desvenlafaxine 25 and 50▒mg/day in a randomized, placebo-controlled study of depressed outpatients.
    Iwata N, Tourian KA, Hwang E, Mele L, Vialet C.
    J Psychiatr Pract; 2013 Jan; 19(1):5-14. PubMed ID: 23334675
    [Abstract] [Full Text] [Related]

  • 8. Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo.
    Dunlop BW, Reddy S, Yang L, Lubaczewski S, Focht K, Guico-Pabia CJ.
    J Clin Psychopharmacol; 2011 Oct; 31(5):569-76. PubMed ID: 21869698
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of desvenlafaxine 50 mg compared with placebo in patients with moderate or severe major depressive disorder: a pooled analysis of six randomized, double-blind, placebo-controlled studies.
    Papakostas GI, Culpepper L, Fayyad RS, Musgnung J, Guico-Pabia CJ.
    Int Clin Psychopharmacol; 2013 Nov; 28(6):312-21. PubMed ID: 23881185
    [Abstract] [Full Text] [Related]

  • 10. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT, Shelton RC, Bao W, Guico-Pabia CJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan 03; 48():86-91. PubMed ID: 24096053
    [Abstract] [Full Text] [Related]

  • 11. Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.
    Reddy S, Kane C, Pitrosky B, Musgnung J, Ninan PT, Guico-Pabia CJ.
    Curr Med Res Opin; 2010 Jan 03; 26(1):139-50. PubMed ID: 19919295
    [Abstract] [Full Text] [Related]

  • 12. The effect of desvenlafaxine 50 mg/day on a subpopulation of anxious/depressed patients: a pooled analysis of seven randomized, placebo-controlled studies.
    Kornstein SG, Guico-Pabia CJ, Fayyad RS.
    Hum Psychopharmacol; 2014 Sep 03; 29(5):492-501. PubMed ID: 25196042
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L, Pitrosky B, Padmanabhan SK, Germain JM, Tourian KA.
    Int Clin Psychopharmacol; 2007 Nov 03; 22(6):338-47. PubMed ID: 17917552
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.
    DeMartinis NA, Yeung PP, Entsuah R, Manley AL.
    J Clin Psychiatry; 2007 May 03; 68(5):677-88. PubMed ID: 17503976
    [Abstract] [Full Text] [Related]

  • 15. Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial.
    Pinkerton JV, Archer DF, Guico-Pabia CJ, Hwang E, Cheng RF.
    Menopause; 2013 Jan 03; 20(1):38-46. PubMed ID: 23266839
    [Abstract] [Full Text] [Related]

  • 16. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.
    Soares CN, Kornstein SG, Thase ME, Jiang Q, Guico-Pabia CJ.
    J Clin Psychiatry; 2009 Oct 03; 70(10):1365-71. PubMed ID: 19906341
    [Abstract] [Full Text] [Related]

  • 17. Analysis of depressive symptoms in patients with major depressive disorder treated with desvenlafaxine or placebo.
    Kornstein SG, Fava M, Jiang Q, Tourian KA.
    Psychopharmacol Bull; 2009 Oct 03; 42(3):21-35. PubMed ID: 19752839
    [Abstract] [Full Text] [Related]

  • 18. Analysis by age and sex of efficacy data from placebo-controlled trials of desvenlafaxine in outpatients with major depressive disorder.
    Kornstein SG, Clayton AH, Soares CN, Padmanabhan SK, Guico-Pabia CJ.
    J Clin Psychopharmacol; 2010 Jun 03; 30(3):294-9. PubMed ID: 20473066
    [Abstract] [Full Text] [Related]

  • 19. Predictors of functional improvement in employed adults with major depressive disorder treated with desvenlafaxine.
    Lam RW, Endicott J, Hsu MA, Fayyad R, Guico-Pabia C, Boucher M.
    Int Clin Psychopharmacol; 2014 Sep 03; 29(5):239-51. PubMed ID: 24583567
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.